文献速递结核与非结核分枝杆菌

结核病预防:当前策略与未来方向

Tuberculosis prevention: current strategies and future directions.
PubMed 文献 · Clin Microbiol Infect · 2023-10-31

本文综述结核病预防的最新证据与进展,指出全球约四分之一人口感染结核分枝杆菌,其中5-10%在一生中发展为结核病;结核病表现呈从感染到疾病的动态谱系而非二元状态。文章聚焦卡介苗与新型候选疫苗、潜伏感染检测、预防性治疗方案,以及低负担与高负担环境下的推荐,强调需多管齐下应对社会决定因素并扩大检测与短程预防治疗的可及性。

要点

  • 全球约四分之一人口感染结核分枝杆菌,其中5-10%在一生中发展为结核病。
  • 结核病表现呈从感染到疾病的动态谱系,而非历史上概念化的二元状态。
  • 疫苗接种、感染检测和提供预防性治疗是结核病预防的关键要素。

核心结论

  • 有效预防结核病需采取多管齐下 approach,应对社会决定因素,并改善结核病检测和新型短程结核病预防治疗方案的可及性。
  • 需要有力合作与创新研究,以降低全球结核病负担,并开发服务于所有人群和年龄的新检测工具、疫苗和预防性治疗。

研究设计与样本

  • 本文为综述,检索文献中的相关研究并综合其结果,概述结核病预防策略的现状与最新研究进展。
  • 综述内容涵盖卡介苗(M. bovis Bacille-Calmette-Guérin)疫苗接种与新型候选疫苗、结核分枝杆菌潜伏感染检测、结核病预防治疗可用方案,以及低负担与高负担环境下的推荐。

主要发现

  • 据估计全球四分之一人口感染结核分枝杆菌,其中5-10%在一生中发展为结核病。
  • 当前证据表明结核病表现沿从感染到疾病的动态谱系发生,而非历史上概念化的二元状态。
  • 阐明这些状态之间转换的决定因素,对降低结核病负担和实现WHO定义的END-TB Strategy目标至关重要。
  • 疫苗接种、感染检测和提供预防性治疗是结核病预防的关键要素。

临床怎么用

  • 作者提出,全球有效预防结核病需采取多管齐下 approach,应对社会决定因素,并改善结核病检测和新型短程结核病预防治疗方案的可及性。
  • 作者提出,需要有力合作与创新研究,以降低全球结核病负担,并开发服务于所有人群和年龄的新检测工具、疫苗和预防性治疗。
  • 原文未据此给出具体推荐条款。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An estimated one fourth of the world's population is infected with Mycobacterium tuberculosis, and 5-10% of those infected develop tuberculosis in their lifetime. Preventing tuberculosis is one of the most underutilized but essential components of curtailing the tuberculosis epidemic. Moreover, current evidence illustrates that tuberculosis manifestations occur along a dynamic spectrum from infection to disease rather than a binary state as historically conceptualized. Elucidating determinants of transition between these states is crucial to decreasing the tuberculosis burden and reaching the END-TB Strategy goals as defined by the WHO. Vaccination, detection of infection, and provision of preventive treatment are key elements of tuberculosis prevention. OBJECTIVES: This review provides a comprehensive summary of recent evidence and state-of-the-art updates on advancements to prevent tuberculosis in various settings and high-risk populations. SOURCES: We identified relevant studies in the literature and synthesized the findings to provide an overview of the current state of tuberculosis prevention strategies and latest research developments. CONTENT: We present the current knowledge and recommendations regarding tuberculosis prevention, with a focus on M. bovis Bacille-Calmette-Guérin vaccination and novel vaccine candidates, tests for latent infection with M. tuberculosis, regimens available for tuberculosis preventive treatment and recommendations in low- and high-burden settings. IMPLICATIONS: Effective tuberculosis prevention worldwide requires a multipronged approach that addresses social determinants, and improves access to tuberculosis detection and to new short tuberculosis preventive treatment regimens. Robust collaboration and innovative research are needed to reduce the global burden of tuberculosis and develop new detection tools, vaccines, and preventive treatments that serve all populations and ages.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Vasiliu A, Martinez L, Gupta RK, et al. Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2023. PMID: 37918510. doi:10.1016/j.cmi.2023.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。